483 results on '"Dalela D"'
Search Results
2. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma
3. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma
4. The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach
5. Benefit of lymph node dissection in cn+ patients in the treatment of upper tract urothelial carcinoma: Analysis of ncdb registry
6. External validation of the Bladder Cancer Research Consortium (BCRC) nomogram for predicting survival after radical cystectomy
7. Evaluation of the utility of lymph-vascular invasion as an independent prognostic predictor of overall survival for patients with renal cell carcinoma that undergo nephrectomy
8. Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder
9. Selective estrogen receptor modulators for BPH: new factors on the ground
10. A Novel Midline Scroto-perineal Approach Facilitating Innervation Preserving Sphincteroplasty and Radical Corporal Detachment for Reconstruction of Exstrophy-epispadias
11. Association of benign prostatic hyperplasia (BPH) with the metabolic syndrome (MS) and its components – ‘a growing dilemma’
12. Evaluation of urinary XIAP as a diagnostic biomarker of carcinoma of urinary bladder
13. National Cancer Database analysis assessing the impact of treatment modalities on survival outcomes in localized neuroendocrine prostate adenocarcinoma
14. Anti-androgen therapy overcomes the time-delay in initiation of salvage radiation therapy and rescues the oncological outcomes in men with recurrent prostate cancer after radical prostatectomy: A post-hoc analysis of the RTOG 9601 trial data
15. Estimating recurrence free survivability of Non-Muscle Invasive Bladder Cancer (NMIBC) after intravesical therapy: A clinical-based recursive partition analysis
16. Recurrence-free survival following resection of low-grade, Non-Muscle-Invasive Urothelial Cancer (NMIBC): A Southwest Oncology Group (SWOG) S0337 post-hoc analysis
17. PT182 - Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort
18. Barriers to hormone replacement therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
19. Reproductive decision making and partnering in BRCA1/2 mutation carriers
20. Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort
21. External validation of genomic classifier based risk-stratification tool to identify candidates for adjuvant radiation therapy in patients with prostate cancer
22. Identifying patients that may benefit from addition of bicalutamide to salvage radiation therapy in the setting of biochemical failure after radical prostatectomy
23. Impact of treatment modality on overall survival (OS) in localized ductal prostate adenocarcinoma (PCa): A national cancer database (NCDB) analysis
24. Does concomitant anti-androgen therapy improve outcomes in patients with recurrent prostate cancer undergoing early salvage radiation therapy
25. External validity of the Stephenson nomogram predicting the outcomes of prostate cancer patients treated salvage radiotherapy after radical prostatectomy: The importance of genomic data
26. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis
27. Confirmation of the correct placement of lower end of DJ stent during open surgery: Point of technique
28. A0901 - External validation of the Bladder Cancer Research Consortium (BCRC) nomogram for predicting survival after radical cystectomy
29. Vesical Calculi With Unrepaired Vesicovaginal Fistula: A Clinical Appraisal of an Uncommon Association
30. Transurethral circum-apical incision of the prostate: minimizing sphinteric injury during transvesical prostatectomy for large prostates
31. A simple method of treating priapism in children
32. Large vesical calculus in a cystocoele: an uncommon cause of irreducible genital prolapse
33. Defining the indications for pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients within a statewide quality improvement collaborative
34. Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma
35. Rates and patterns of metastases in patients with node-negative prostate cancer at radical prostatectomy that experience PSA failure: Post-hoc analysis of RTOG 9601 trial data
36. Inpatient morbidity and cost of cytoreductive radical prostatectomy in the United States
37. Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis
38. The changing face of surgically treated low-risk prostate cancer (PCa): A national cancer database (NCDB) analysis
39. Evaluating the impact of lead-time bias on the observed efficacy of early salvage radiation therapy in prostate cancer: A post-hoc analysis of the RTOG 9601 trial
40. Menon-precision prostatectomy (MPP): An idea, development, exploration, assessment, long-term follow-up (IDEAL) stage 1 study
41. Persistent under-utilization of adjuvant radiotherapy in patients with adverse pathological features at radical prostatectomy: A national cancer database (NCDB) analysis
42. The single ectopic ureter
43. Bilateral simultaneous ESWL: A safety-efficacy analysis
44. "PARATESTICULAR SOFT TISSUE FLAP" : AN ALTERNATIVE FOR POSTPUBECTOMY DEAD SPACE OBLITERATION AND NEOANASTOMOSIS PROTECTION IN URETHROPLASTY
45. 951 - Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model
46. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
47. Assessing the external validity of the updated prostate cancer (PCa) intervention versus observation trial (PIVOT)
48. Testing the impact of adjuvant radiotherapy (aRT) after radical prostatectomy (RP) on overall mortality (OM) in prostate cancer patients with pathologically node positive disease: A nationwide analysis
49. Harvesting Buccal Mucosa Graft Under Local Infiltration Analgesia—Mitigating Need for General Anesthesia
50. Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.